ArticleJournal of nanobiotechnology2026
Dual-single-atom nanozyme with stage-adaptive catalytic regulation for infected diabetic wound healing.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Infected diabetic wounds remain difficult to treat because persistent bacterial reservoirs coexist with a failure to transition from antibacterial defense to regenerative repair. Here, we report a dual-single-atom nanozyme (FeCo-CN) in which atomically dispersed Fe and Co centers are anchored within a nitrogen-coordinated carbon framework, enabling stage-adaptive regulation of the wound microenvironment. During the early infection phase, FeCo-CN exhibits photothermal-enhanced peroxidase-like activity that efficiently reduces extracellular bacteria and promotes macrophage-mediated intracellular bacterial clearance. As the bacterial burden decreases, the material shows superoxide dismutase- and catalase-like activities that alleviate oxidative stress, preserve mitochondrial function, and favor the shift toward reparative immune responses. These coordinated effects support angiogenesis and tissue regeneration. Overall, this work highlights a dual-single-atom nanozyme strategy that integrates infection control with immune transition and tissue repair in infected diabetic wounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.